Co-Diagnostics (CODX) 2025 Earnings: Catalysts & Risks
Investors are keeping a close eye on Co-Diagnostics as 2025 earnings unfold. This guide breaks down what to look for ...
Deciding between cash back and rewards cards depends on your spending habits. Analyze your needs to find the best option for you.
26,062 articlesInvestors are keeping a close eye on Co-Diagnostics as 2025 earnings unfold. This guide breaks down what to look for ...
A U.S. regulator just opened a door for an ambitious ocean mining player. This article breaks down what the NOAA appr...
When a big fund trims its stake, it can spark questions and quick moves. This guide breaks down what investors should...
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
June opened with volatility as Nu Holdings faced a fresh downgrade and a leadership transition. This article breaks d...
In mid-June, hawkish central bank signals set the tone for global markets. The FTSE 100 faltered while the Nikkei 225...
A hypothetical six-word message from the Fed chair could reshape market expectations. This article breaks down what t...
As the SaaS crowd sinks, AI-powered software names may rise to the occasion in 2026. This article explains why and po...
As AI workloads push data-center networks to the limit, Ciena could be uniquely positioned to turn a hidden opportuni...
An executive stock sale can signal many things. This article breaks down the numbers, the reporting rules, and practi...
Grayscale argues that saylor’s strategy $1.5bb cashflow is being squeezed by a growing load of preferred-stock obliga...
JPMorgan Chase just paired a 10% dividend hike with a $50 billion buyback after clearing the Fed's stress test. Here'...